Endothelial Protein C Receptor Function in Murine and Human Breast Cancer Development

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Schaffner, Florence ^a,e   Yokota, Naho ^a   Carneiro Lobo, Tatiana ^a   Kitano, Maki ^a   Schaffer, Michael ^b   Anderson, G Mark ^b   Mueller, Barbara M ^c   Esmon, Charles T ^d   Ruf, Wolfram ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^e UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL PROTEIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CANCER STEM CELL LIKE POPULATION; CELL POPULATION; CELL SUBPOPULATION; CONTROLLED STUDY; GENE EXPRESSION; IN VIVO STUDY; MAMMARY GLAND; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MICROARRAY; TRIPLE NEGATIVE BREAST CANCER; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

ADIPOSE TISSUE; ANIMALS; ANTIGENS, CD; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GLYCOPROTEINS; HUMANS; MACROPHAGES; MAMMARY GLANDS, ANIMAL; MICE; NEOPLASTIC STEM CELLS; RECEPTORS, CELL SURFACE; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

MURINAE; MUS;

EID: 84876043765     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061071     Document Type: Article

References (61)

1. Muller F, Mutch NJ, Schenk WA, Smith SA, Esterl L, et al. (2009) Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139: 1143-1156.
2. Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, et al. (2007) Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 104: 6388-6393.
3. Ruf W, Edgington TS, (1994) Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 8: 385-390.
4. Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, et al. (2004) Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nature Med 10: 502-509.
5. Ruf W, Disse J, Carneiro-Lobo TC, Yokota N, Schaffner F, (2011) Tissue factor and cell signalling in cancer progression and thrombosis. J Thromb Haemost 9 Suppl 1: 306-315.
6. Ruf W, Mueller BM, (2006) Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost 32: 61-68.
7. Schaffner F, Versteeg HH, Schillert A, Yokota N, Petersen LC, et al. (2010) Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. Blood 116: 6106-6113.
8. Versteeg HH, Schaffner F, Kerver M, Petersen HH, Ahamed J, et al. (2008) Inhibition of tissue factor signaling suppresses tumor growth. Blood 111: 190-199.
9. Gessler F, Voss V, Dutzmann S, Seifert V, Gerlach R, et al. (2010) Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells. Neuroscience 165: 1312-1322.
10. Ryden L, Grabau D, Schaffner F, Jonsson PE, Ruf W, et al. (2010) Evidence for tissue factor phosphorylation and its correlation with protease activated receptor expression and the prognosis of primary breast cancer. Int J Cancer 126: 2330-2340.
11. Albrektsen T, Sorensen BB, Hjortoe GM, Fleckner J, Rao LVM, et al. (2007) Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells. J Thromb Haemost 5: 1588-1597.
12. Nierodzik ML, Karpatkin S, (2006) Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10: 355-362.
13. Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, et al. (2005) PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells. Cell 120: 303-313.
14. Esmon CT, (2006) The endothelial protein C receptor. Curr Opin Hematol 13: 382-385.
15. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W, (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296: 1880-1882.
16. Riewald M, Ruf W, (2005) Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling. J Biol Chem 280: 19808-19814.
17. Mosnier LO, Zlokovic BV, Griffin JH, (2006) The cytoprotective protein C pathway. Blood 109: 3161-3172.
18. Bezuhly M, Cullen R, Esmon CT, Morris SF, West KA, et al. (2009) Role of activated protein C and its receptor in inhibition of tumor metastasis. Blood 113: 3371-3374.
19. Beaulieu LM, Church FC, (2007) Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1. Exp Cell Res 313: 677-687.
20. Anton I, Molina E, Luis-Ravelo D, Zandueta C, Valencia K, et al. (2012) Receptor of Activated Protein C Promotes Metastasis and Correlates with Clinical Outcome in Lung Adenocarcinoma. Am J Respir Crit Care Med 186: 96-105.
21. Disse J, Petersen HH, Larsen KS, Persson E, Esmon N, et al. (2011) The Endothelial Protein C Receptor Supports Tissue Factor Ternary Coagulation Initiation Complex Signaling through Protease-activated Receptors. J Biol Chem 286: 5756-5767.
22. Ghosh S, Pendurthi UR, Steinoe A, Esmon CT, Rao LV, (2007) Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem 282: 11849-11857.
23. Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, et al. (2002) A stem cell molecular signature. Science 298: 601-604.
24. Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E, (2004) Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell 118: 635-648.
25. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA, (2002) "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298: 597-600.
26. Balazs AB, Fabian AJ, Esmon CT, Mulligan RC, (2005) Endothelial protein C receptor (CD201) explicitly identifies hematopoietic stem cells in murine bone marrow. Blood 107: 2317-2321.
27. Park SY, Lee HE, Li H, Shipitsin M, Gelman R, et al. (2010) Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 16: 876-887.
28. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF, (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
29. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
30. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, et al. (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell 11: 259-273.
31. Hsu YC, Fuchs E, (2012) A family business: stem cell progeny join the niche to regulate homeostasis. Nat Rev Mol Cell Biol 13: 103-114.
32. Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, et al. (2011) Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A 108: 7950-7955.
33. Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 323-334.
34. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, et al. (2010) Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6: 421-432.
35. Hwang-Verslues WW, Kuo WH, Chang PH, Pan CC, Wang HH, et al. (2009) Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. PLoS ONE 4: e8377.
36. Guy CT, Cardiff RD, Muller WJ, (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 12: 954-961.
37. Versteeg HH, Schaffner F, Kerver M, Ellies LG, Andrade-Gordon P, et al. (2008) Protease activated receptor (PAR)2, but not PAR1 signaling promotes the development of mammary adenocarcinoma in PyMT mice. Cancer Res 68: 7219-7227.
38. Castellino FJ, Liang Z, Volkir SP, Haalboom E, Martin JA, et al. (2002) Mice with a severe deficiency of the endothelial protein C receptor gene develop, survive, and reproduce normally, and do not present with enhanced arterial thrombosis after challenge. Thromb Haemost 88: 462-472.
39. Li W, Zheng X, Gu JM, Ferrell GL, Brady M, et al. (2005) Extraembryonic expression of EPCR is essential for embryonic viability. Blood 106: 2716-2722.
40. Jessani N, Humphrey M, McDonald WH, Niessen S, Masuda K, et al. (2004) Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. Proc Natl Acad Sci U S A 101: 13756-13761.
41. Disse J, Ruf W, (2011) Endothelial protein C receptor is required for tissue factor ternary complex signaling in the mouse. J Thromb Haemost 9: 2516-2518.
42. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, et al. (2011) Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146: 633-644.
43. Dorfleutner A, Hintermann E, Tarui T, Takada Y, Ruf W, (2004) Crosstalk of integrin α3β1 and tissue factor in cell migration. Mol Biol Cell 15: 4416-4425.
44. Qian H, Tryggvason K, Jacobsen SE, Ekblom M, (2006) Contribution of alpha6 integrins to hematopoietic stem and progenitor cell homing to bone marrow and collaboration with alpha4 integrins. Blood 107: 3503-3510.
45. Schober M, Fuchs E, (2011) Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-beta and integrin/focal adhesion kinase (FAK) signaling. Proc Natl Acad Sci U S A 108: 10544-10549.
46. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507.
47. Anastassiou D, Rumjantseva V, Cheng W, Huang J, Canoll PD, et al. (2011) Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. BMC Cancer11529: 529.
48. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, et al. (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66: 11238-11246.
49. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT, (1996) The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 93: 10212-10216.
50. Liaw PCY, Mather T, Oganesyan N, Ferrell G, Esmon CT, (2001) Identification of the protein C/activated protein C binding sites on the endothelial cell protein C receptor. J Biol Chem 276: 8364-8370.
51. Koizume S, Jin M-S, Miyagi E, Hirahara F, Nakamura Y, et al. (2006) Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. Cancer Res 66: 9453-9460.
52. Chapman HA Jr, Allen CL, Stone OL, Fair DS, (1985) Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease. J Clin Invest 75: 2030-2037.
53. Netzel-Arnett S, Hooper JD, Szabo R, Madison EL, Quigley JP, et al. (2003) Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev 22: 237-258.
54. Magee JA, Piskounova E, Morrison SJ, (2012) Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell %20 21: 283-296.
55. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, et al. (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69: 4116-4124.
56. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
57. Kim J, Villadsen R, Sorlie T, Fogh L, Gronlund SZ, et al. (2012) Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proc Natl Acad Sci U S A 109: 6124-6129.
58. Qian BZ, Pollard JW, (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
59. Kerschen E, Hernandez I, Zogg M, Jia S, Hessner MJ, et al. (2010) Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice. J Clin Invest 120: 3167-3178.
60. Kerschen EJ, Fernandez JA, Cooley BC, Yang XV, Sood R, et al. (2007) Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med 204: 2439-2448.
61. Taylor FB Jr, Stearns-Kurosawa DJ, Kurosawa S, Ferrell G, Chang ACK, et al. (2000) The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95: 1680-1686.